Big Cypress Acquisition Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCYP research report →
Price Chart
About the company
Big Cypress Acquisition Corp. (BCYP) aims to acquire businesses and assets. This is accomplished through various strategies, including mergers, stock purchases, capital stock exchanges, reorganizations, or comparable business integrations.
- CEO
- Samuel J. Reich
- IPO
- 2021
- HQ
- Miami Beach, FL, US
Get TickerSpark's AI analysis on BCYP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $425.36M
- P/E
- -8.44
- PEG
- 0.17
- P/S
- 0.00
- P/B
- 3.13
- EV/EBITDA
- -73.61
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -6.74%
- ROIC
- -31.62%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-48,953,363
- Net Income
- $13.27M+138.9%
- EPS
- $0.22+106.0%
- OCF Growth
- -30.6%
- FCF Growth
- -30.6%
- 52W High
- $12.90
- 52W Low
- $7.30
- 50D MA
- $8.37
- 200D MA
- $8.37
- Beta
- 0.00
- RSI (14)
- 25
- Avg Volume
- 2.27M
No earnings-call transcripts are available for BCYP yet.
- Free Float
- 60.6%
- Shares Outstanding
- 50.40M
- Float Shares
- 30.55M
of shares held by institutions
38 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 11, 21 | Martin James Joseph | other | 0 |
| Dec 27, 16 | MERRIMAN D JONATHAN | other | 100,000 |
| Apr 10, 15 | MERRIMAN D JONATHAN | other | 1,000,000 |
| Dec 18, 14 | MERRIMAN D JONATHAN | other | 375,000 |
| Dec 18, 14 | MERRIMAN D JONATHAN | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BCYP coverage
Recent articles, reports, and earnings notes.
No research on BCYP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCYP report →Big Cypress Acquisition (OTCMKTS:BCYP) Shares Pass Below Two Hundred Day Moving Average – What’s Next?
defenseworld.net · Apr 17
Big Cypress Acquisition (OTCMKTS:BCYP) Shares Pass Below 200-Day Moving Average – Here’s What Happened
defenseworld.net · Apr 1
Analyzing Inhibikase Therapeutics (NYSE:IKT) and Big Cypress Acquisition (OTCMKTS:BCYP)
defenseworld.net · Feb 18
Big Cypress Acquisition (OTCMKTS:BCYP) Stock Price Crosses Above 50-Day Moving Average – Here’s Why
defenseworld.net · Feb 11
Comparing Inhibikase Therapeutics (NYSE:IKT) and Big Cypress Acquisition (OTCMKTS:BCYP)
defenseworld.net · Feb 6
Big Cypress Acquisition (OTCMKTS:BCYP) Shares Cross Below Fifty Day Moving Average – Here’s Why
defenseworld.net · Jan 27
SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19
businesswire.com · Sep 24
Big Cypress Acquisition Corp Announces Special Meeting of Stockholders to Approve Business Combination with SAB Biotherapeutics
prnewswire.com · Sep 23
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.